Regenxbio (RGNX) Capital Expenditures Growth (1y) (2016 - 2025)
Regenxbio (RGNX) Capital Expenditures Growth (1y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Regenxbio |
325.94 Mn |
95.87 Mn |
- |
-194.25% |
| Date | Value |
|---|
| Dec 31, 2025 |
-194.25% |
| Sep 30, 2025 |
50.61% |
| Jun 30, 2025 |
-17.51% |
| Mar 31, 2025 |
83.84% |
| Dec 31, 2024 |
-4.17% |
| Sep 30, 2024 |
-77.35% |
| Jun 30, 2024 |
-81.61% |
| Mar 31, 2024 |
-88.44% |
| Dec 31, 2023 |
-79.41% |
| Sep 30, 2023 |
-71.50% |
| Jun 30, 2023 |
-72.10% |
| Mar 31, 2023 |
-56.07% |
| Dec 31, 2022 |
-62.57% |
| Sep 30, 2022 |
-72.99% |
| Jun 30, 2022 |
-53.45% |
| Mar 31, 2022 |
-64.65% |
| Dec 31, 2021 |
-45.52% |
| Sep 30, 2021 |
337.83% |
| Jun 30, 2021 |
505.31% |
| Mar 31, 2021 |
570.00% |
